Jame Abraham, MD

• Chairman, Cleveland Clinic Department of Hematology & Medical Oncology
• Professor of Medicine, Cleveland Clinic Lerner College of Medicine
• Medical Director, Community Outreach, Taussig Cancer Institute
• Member, NCCN, Breast Cancer Committee
• Vice Chair, Research Strategy, NRG Oncology
• Co-Director, Cleveland Clinic Comprehensive Breast Cancer Program (2013-2019)
• Member, Breast Cancer Working Committee, NRG Oncology (2019- 2022)
• Member, Breast Cancer Committee, NRG Oncology (2015-Present)    
• Member, Translational Research Committee, NRG Oncology (2015-18)
• Co-Principal Investigator, Leading Academic Participating Sites (LAPS), National Cancer Institute  grant for the Case Comprehensive Cancer Center (2014-2017)
• Principal Investigator of NSABP for Cleveland Clinic (2013 to present)
• Vice Chair, Research Review Committee, NSABP Foundation (2013-Present)
• Member of Breast Cancer Working Group, NSABP (2010-2013)
• Founding Editor of Bethesda Handbook of Clinical Oncology, Wolter Kluwer, Philadelphia (5th edition)
• Chief Editor, Emerging Cancer Therapeutics, Demos, New York
• Editor, Community and Supportive Care Oncology (Frontline Communications, NJ)
• Editor, Breast Cancer Management and Treatment (London, U.K)
• Associate Editor and Guest Editor, ASCO Post (Harborside Press, NY)
• Board of Directors, American Cancer Society, South Atlantic Division (2007-2010)
  • Editorial Board Member:
    • Journal of Breast Cancer Management, Future Science Group, London, U.K, Oncology and Biotechnology News, New Jersey, Expert Review of Anticancer Therapy, Future Science Group, London, U.K.
  • Manuscript Reviewer:
    • Lancet Oncology, Lancet
    • Journal of Clinical Oncology, ASCO
    • Clinical Cancer Research Focus, AACR
    • Human Bain Mapping
    • Expert Review of Immunotherapy
    • Clinical Breast Disease
    • British Journal of Cancer, Nature Publications Group
    • Annals of Saudi Medicine
    • Clinical Cancer Research, AACR
    • Expert Review of Anticancer Therapy
    • Cancer: American Cancer Society
    • Cancer Chemotherapy and Pharmacology

• Senior Fellow, Developmental Therapeutics, National Cancer Institute 2001
• Leadership Development for Physicians in Academic Health Centers, School of Public Health, Harvard, Boston. 2006

• Teacher of the Year Award: Oncology, Taussig Cancer Institute, Cleveland Clinic, 2016
• Top Doctors in Cleveland 2014, 2015, 2016, 2017, 2018 -  Cleveland Magazine
• Top Cancer Doctors in U.S, Newsweek, 2015
• U.S. News Top Doctor, Castle Connolly Medical Ltd, 2010 to 2018  
• Selected to the Gold Human Honor Society (GHHS), 2011
• “Pink Tie Guy” – Selected by Susan G. Komen for the Cure, WV 2010
• Dean’s Award for Excellence in Clinical Medicine, School of Medicine, West Virginia University, 2010
• Quality Award (Customer Satisfaction), West Virginia University Hospitals, 2006-2013
• President of India, Her Excellency, Smt. Pratibha Patil “Vaidya Bhooshan”, by the Pazhassi Raja Trust, New Delhi, India, 2010
• Bonnie Wells Wilson Eminent Scholar and Distinguished Professor in Breast Cancer Research, 2009
• Outstanding Achievement in Medicine, Kerala Center, India League, New York, 2008
• Outstanding Faculty Award, Department of Medicine, West Virginia University, 2007
• STAR Award for customer service, West Virginia University Hospital, 2006
• Clinician of the Year Award, Department of Medicine, West Virginia University, 2006
• Volunteer of the Year Award for the state of West Virginia, American Cancer Society (ACS) 2006

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-04-28, Dr. Abraham has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Abraham receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Clinical Care Options, LLC

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.